Table:
begin	end	state
1	30	cytoplasmic
31	56	transmembrane
57	67	non-cytoplasmic
68	85	transmembrane
86	96	cytoplasmic
97	117	transmembrane
118	122	non-cytoplasmic
123	143	transmembrane
144	160	cytoplasmic
161	181	transmembrane
182	186	non-cytoplasmic
187	209	transmembrane
210	270	cytoplasmic
271	293	transmembrane
294	308	non-cytoplasmic
309	330	transmembrane
331	338	cytoplasmic
339	360	transmembrane
361	366	non-cytoplasmic
367	393	transmembrane
394	404	cytoplasmic
405	425	transmembrane
426	434	non-cytoplasmic
435	455	transmembrane
456	472	cytoplasmic

Input:
>AO356_27270
MTINSYGNTADTSATFVSPEKHQAQRYLQKITWIATFGGLLFGFDTGVINGALLYMKDDL
GLTPFTEGLVASALLIGAMMGALFSGRLSDLKGRRRIILFLAVVFFLGALACALAPTLNV
MVAARFTLGLAVGGASVVVPAYLAEMAPSSIRGRIITRNELMIVTGQFLAFTTNATLGNL
FSDLDGVWRWMLALATLPAVALWLGMLYMPESPRWLATKGRFREGLEVLKLVREEYYAKA
EMEAITQQISNERFIKKGGWRDLSQKGARRIFLIGIGIAVTSQLTGVNSIMYFGTQILTE
AGLEQRSALIANVVNGVISIGATFVGIALLDRVGRRPMMLLGFTGTTLSLLLIGLVSVFV
DPSVTRAMLILGAMAMFLASMQGLIGPAFWVLLAEIFPMRIRGGCMGMAIAAFWLTNVMI
GMFFPSLVATIGIGQTFFVFVGAGLLSLTFVAVWVPETRGSTLEEIEQRLYG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server